IRIS
TREPPO, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.001
NA - Nord America 748
EU - Europa 373
SA - Sud America 172
AF - Africa 26
OC - Oceania 4
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 719
SG - Singapore 496
CN - Cina 156
BR - Brasile 144
VN - Vietnam 124
HK - Hong Kong 100
IT - Italia 92
RU - Federazione Russa 55
FR - Francia 45
DE - Germania 40
FI - Finlandia 24
KR - Corea 23
IN - India 22
GB - Regno Unito 20
CA - Canada 14
IE - Irlanda 14
AR - Argentina 13
AT - Austria 13
PL - Polonia 13
NL - Olanda 12
PK - Pakistan 11
BD - Bangladesh 10
JP - Giappone 10
SE - Svezia 10
ZA - Sudafrica 10
IQ - Iraq 9
UZ - Uzbekistan 7
ES - Italia 6
MX - Messico 6
BE - Belgio 5
CO - Colombia 5
ID - Indonesia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
TG - Togo 4
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HR - Croazia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
OM - Oman 3
UA - Ucraina 3
CH - Svizzera 2
EC - Ecuador 2
EG - Egitto 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.326
Salva come PNG Salva come JPEG
Città #
Singapore 232
Ashburn 160
Hong Kong 92
Beijing 69
San Jose 47
Ho Chi Minh City 34
Lauterbourg 33
Boardman 31
Los Angeles 31
Chandler 29
Hefei 25
Hanoi 23
Seoul 23
Dallas 21
Council Bluffs 18
Redondo Beach 17
Helsinki 16
Frankfurt am Main 15
Dublin 14
Milan 14
New York 14
São Paulo 14
Buffalo 13
The Dalles 13
Warsaw 13
Dong Ket 12
Ann Arbor 11
Belluno 11
Nuremberg 11
Santa Clara 11
Düsseldorf 9
Wilmington 9
Woodbridge 9
Denver 8
Houston 8
Lappeenranta 8
Mumbai 8
Princeton 8
Stockholm 8
Tokyo 8
Udine 8
Amsterdam 7
Brooklyn 7
Fairfield 7
London 7
Seattle 7
Tashkent 7
Cambridge 6
Johannesburg 6
Lahore 6
Ogden 6
Toronto 6
Biên Hòa 5
Florence 5
Haiphong 5
Taranto 5
Vienna 5
Athens 4
Atlanta 4
Brussels 4
Chennai 4
Da Nang 4
Jakarta 4
Lomé 4
Newark 4
Phoenix 4
Rimini 4
Trieste 4
Xi'an 4
Boston 3
Campinas 3
Chicago 3
Christchurch 3
Colombo 3
Crema 3
Guarulhos 3
Hải Dương 3
Lucca 3
Montreal 3
North Bergen 3
Orem 3
Querétaro 3
Rio de Janeiro 3
Rosario 3
Vũng Tàu 3
Albufeira 2
Amman 2
Ankara 2
Asunción 2
Basra 2
Belo Horizonte 2
Bergamo 2
Bắc Giang 2
Calgary 2
Can Tho 2
Codroipo 2
Des Moines 2
Dhaka 2
Duque de Caxias 2
Guangzhou 2
Totale 1.381
Salva come PNG Salva come JPEG
Nome #
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 110
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 109
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 106
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 103
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 99
Sjögren's disease and systemic lupus erythematosus overlap syndrome as distinct entity at the crossroads of two autoimmune disorders: clinical characterisation from two Italian reference centres for both diseases 91
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 89
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 87
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren's disease: a monocentric cohort study 87
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 83
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 82
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 79
Systemic vasculitis: one year in review 2023 73
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 73
Systemic vasculitis: one year in review 2022 73
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 72
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres 71
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 70
Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome 69
Systemic vasculitis: one year in review 2024 68
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 67
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 66
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 66
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 65
Paraproteinemias Associated with Autoimmune Diseases 62
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis 61
Rheumatologic manifestations of Hepatitis C Virus 59
Mass-Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report 52
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 51
One year in review 2020: vasculitis 50
One year in review 2021: systemic vasculitis 49
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets 40
Systemic vasculitis: one year in review 2025 39
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 28
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature 17
Totale 2.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 4 4 13
2021/202258 4 2 6 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/2025839 14 73 44 28 35 31 83 69 118 61 143 140
2025/20261.297 150 165 129 114 247 149 144 44 73 82 0 0
Totale 2.466